Test Price
2,800 AED✅ Home Collection Available
STRADA Gene Polyhydramnios, Megalencephaly, and Symptomatic Epilepsy Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity for STRADA pathogenic variants via ISO 9001:2015 accredited next-generation sequencing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic post-test result interpretation by a DHA-licensed Consultant Medical Geneticist.
- Insurance Support: Direct billing verification via WhatsApp at +971 54 548 8731 – coverage confirmed before sample collection.
Test Overview & Methodology
The STRADA Gene Genetic Test sequences the entire coding region of the STRADA gene using next-generation sequencing (NGS) to identify pathogenic variants causing Polyhydramnios, Megalencephaly, and Symptomatic Epilepsy (PMSE) syndrome. This test provides definitive molecular diagnosis for affected infants and carrier screening for at-risk family members, enabling early intervention and targeted seizure management.
| Feature | DNA Labs UAE NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% sensitivity, full gene coverage | ~95% sensitivity, limited to known hotspots |
| Method | Next Generation Sequencing (NGS) – comprehensive | Sanger sequencing of targeted exons |
| Speed (TAT) | 3–4 Weeks | 6–8 Weeks |
Physician Insight & Safety Protocols
Insight from Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
"Identifying a pathogenic STRADA variant confirms PMSE syndrome, yet comprehensive clinical correlation with neuroimaging and EEG remains indispensable. This genetic test empowers families with a definitive molecular answer, enabling early therapeutic intervention, tailored seizure control strategies, and informed family planning. Our team provides meticulous post-test counseling to translate every result into actionable care."
Medication Advisory
Critical: Do not discontinue prescribed antiepileptic or other medications without consulting your treating physician. This genetic test is not a substitute for clinical management; never alter drug regimens solely based on genetic results.
Patient Safety – Exclusion Criteria & ER Red Flags
- Exclusion Criteria: Inability to provide a viable blood sample; active bleeding disorder precluding safe venipuncture; lack of informed consent from legal guardian (mandatory for minors).
- ER Red Flags – Seek immediate medical attention if: New or worsening seizures, respiratory distress, signs of severe intracranial pressure (vomiting, altered consciousness), or any sudden change in neurological status.
- Data Privacy: All genetic data is processed under strict chain-of-custody in an ISO-certified facility, with full compliance to UAE data protection law.
Patient FAQ & Clinical Guidance
1. What exactly does the STRADA gene test detect, and why is it important for my child?
This test identifies pathogenic mutations in the STRADA gene that cause PMSE syndrome, a condition marked by prenatal polyhydramnios, brain overgrowth (megalencephaly), and drug-resistant epilepsy. Early molecular diagnosis enables precise treatment planning and seizure management.
2. How is the test performed, and does my insurance cover it in the UAE?
A simple blood sample is collected via VIP mobile phlebotomy in the comfort of your home, processed with advanced NGS technology at our ISO-accredited laboratory. Most UAE insurers cover the test after medical necessity verification through our direct billing support – contact us at +971 54 548 8731.
3. What should I do if the test result is positive?
A positive result confirms PMSE syndrome. You will receive an immediate teleconsultation with our Consultant Medical Geneticist and a pediatric neurologist to discuss treatment pathways, family screening, and available support resources. Genetic counseling is provided at no additional cost.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance
This service adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is handled with strict confidentiality, never shared without explicit consent, and processed under ISO 9001:2015 accredited protocols (Cert: INT/EGQ/2509DA/3139). Clinical safety and patient consent comply with Federal Decree-Law No. 4 of 2016 on Medical Liability.
DHA Facility License: 1143 | Laboratory Address: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE
Clinical & Logistical Metadata
| Test Name | STRADA Gene Polyhydramnios, Megalencephaly, and Symptomatic Epilepsy (PMSE) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available |
| Methodology Used | Next Generation Sequencing (NGS) – Full Gene Coding Region Sequencing |
| ICD-10-CM Code | Q87.8 (Other specified congenital malformation syndromes) |
| LOINC Code | 55233-1 (Genetic analysis master) |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians